Click Here! Click Here!
Click Here!

American Society of Hematology Annual Meeting & Exposition
San Diego, California
December 1 to 4, 2018

This 60th edition of the ASH meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.
The presidential symposium on December 4 looks at completing the genome editing arc in hematology. Dr. Donald Kohn from the University of California, Los Angeles, will discuss the scientific evolution of gene therapy and genome editing as well as the growing clinical applications of these technologies. Dr. Francis Collins from the National Institutes of health will describe how fundamental advances in our knowledge of hematologic conditions, biology of viral vectors and target cells, and the development of methods to genetically modify cells are contributing to acceleration of the field. Dr. George Daley from Harvard Medical School will discuss the ethical and social challenges that some of these new technologies engender, as well as essential considerations for guidance on all aspects of stem cell research and its clinical translation.
Not to be missed:
The Ham-Wasserman lecture on December 1, Dr. Michael Hallek will summarize some of the key findings that have critically contributed to the progress made over the last decades. He will summarize the major insights regarding the biology of chronic lymphocytic leuemia as well as the technological advances that allow for a better prognostication of the disease.
On December 3, Dr. Connie Evans from the Terry Fox Laboratory, BC Cancer Agency, will give the E. Donnall Thomas lecture, highlighting key advances, future challenges, and exciting opportunities in hematopoietic stem cell research.
Contact: Tel: 202-776-0544; Fax: 202-776-0545; Website:

San Antonio Breast Cancer Symposium
San Antonio, Texas
December 3 to 5, 2018

This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. It is directed primarily towards physicians, other healthcare professionals and researchers involved in breast cancer.
Contact: Tel: 210-450-1550; Email:; Website:

2019 Gastrointestinal Cancers Symposium
San Francisco, California
January 17 to 19, 2019

The theme of this year's meeting is "Multidisciplinary treatment, personalized care, optimal outcomes". ASCO GI is a gathering place for international experts to explore developments in the prevention, screening and treatment of cancers of the esophagus, stomach, pancreas, colon and rectum. Sessions look at topic areas including: management of early stage esophageal cancer, perioperative therapies for gastric cancer, palliation of esophago-gastric malignancies, the evolving landscape of neuroendocrine tumours, and much more.
Contact: Tel: 888-788-1522; Email: or; Website:

Cancer Vaccines
Vancouver, BC
January 20 to 24, 2019

This Keystone Symposia conference will highlight recent insights in the characterization of immunogenic cancer antigens, the biology and underlying mechanisms of T-cell priming, and the development of novel approaches designed to expand T-cell responses. Part of the meeting will also be devoted to the development of technologies to monitor T-cell responses in response to immune interventions. The meeting is organized in collaboration with Cancer Research UK, and sponsored by Genentech, Pfizer and BioLegend.
Contact: Tel: 800-253-0685 or +970-262-1230; Email: info@keystone; Website:

Canadian Lung Cancer Conference
Vancouver, British Columbia
February 7 and 8, 2019

The meeting has a multidisciplinary focus to meet the needs of a wide variety of professionals. Topics appealing to medical oncology, respiratory medicine, radiation oncology and thoracic surgery as well as oncology nursing will be presented. Guest speakers will provide a wealth of expertise and knowledge to optimize the treatment of lung cancer patients.
Chaired by Drs. Barb Melosky and Cheryl Ho, the meeting aims to improve the care of patients with lung cancer, review new approaches to the treatment of NSCLC, discuss the role of radiation oncology in the management of NSCLC, and update surgical options in NSCLC therapy.
A debate will be held on the topic "Dual vs Tri modality treatment."
Contact: HayMatick Meetings and Events, Tel: 778-882-4389; Email:; Website:

Canadian Melanoma Conference
Banff, Alberta
February 21 to 23, 2019

Presented by Oncology Education, this conference brings together medical oncologists, surgeons, dermatologists, radiotherapists, pathologists, molecular biologists, immunologists, and other allied health professionals interested in the treatment of melanoma worldwide. The meeting is chaired by Dr. Scott Ernst and includes presentations on the microbiome and implications to immunotherapy, dermatologic complications of targeted therapy and immunotherapy, systemic approaches in ocular melanoma, immunotherapy combinations and drug funding challenges, and more.
Contact: Email:; Website:

Genitourinary Cancers Symposium
San Francisco, California
February 14 to 16, 2019

This multidisciplinary scientific and educational meeting is the ideal venue to present the latest science and its clinical application to all members of the cancer care community. The theme of the conference is "Translating evidence to multidisciplinary care". The opening session will look at optimizing diagnosis and treatment of clinically significant nonmetastatic prostate cancer. Presentations will address collaborative management of recurrent prostate cancer, perioperative and local therapy for urothelial cancer, rare genitourinary malignancies, localized kidney cancer, and more.
Contact: Tel: 888-282-2552; Email:;

European Association for Cancer Research: Immunooncology
Barcelona, Spain
March 11 to 13, 2019

This conference will look at the most recent advances in the field of immunotherapy, from basic science to clinical studies, including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy. The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of immunotherapy.
Topics to be covered include immune checkpoints, immunoediting, innate immune response, microbioma and the immune system, CAR T cells, vaccination, biomarkers of response to immunotherapy, and mechanisms of resistance to immunotherapy.
Contact: Tel: 44-115-951-5114; Email:; Website:

Canadian Conference on Lymphoproliferative Disorders
Banff, Alberta
March 21 to 24, 2019

This meeting has been designed to meet the educational needs of hematologists, oncologists, general practitioners in oncology, and other healthcare providers involved in the management of patients with lymphoproliferative and plasma cell disorders. It provides a unique opportunity for attendees to interact with international experts in the field of hematologic malignancies. The scope of this meeting will highlight both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients. As in previous meetings the format will be didactic presentations as well as case based panel discussions. There will be opportunity for audience participation via keypad polling devices with the entire faculty featured during the panel discussions. Internationally known researchers in lymphoproliferative disorders will provide keynote lectures and their perspectives on optimal management.
Contact: Tel: 250-714-2591; Email:; Website:

American Society of Clinical Oncology Annual Meeting
Chicago, Illinois
May 31 to June 4 2019

The theme of this year's conference is "Caring for every patient, learning from every patient." The meeting includes case-based sessions, education sessions and workshops. The call for abstracts opens on November 13 and the deadline is February 12, 2019. Tracks include all cancer sites, as well as survivorship, symptom management, developmental therapeutics and health services, clinical informatics and quality of care.
Contact: Tel: 888-282-2552; Email:;

These listings are accurate as of publication date. Details and contact information are provided according to availability. To post an upcoming meeting in the next issue of Oncology Exchange, please contact:
Click Here! Click Here!
© Parkhurst Publishing Privacy Statement
Legal Terms of Use